|
|
TTD Drug ID:
DNC003705
Drug
Information |
Name | Ro-60-0175;Ro-600175 | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C11H12ClFN2/c1-7(14)6-15-3-2-8-4-10(13)9(12)5-11(8)15/h2-5,7H, 6,14H2,1H3/t7-/m0/s1 | InChIKey | XJJZQXUGLLXTHO-ZETCQYMHSA-N | Canonical SMILES | CC(CN1C=CC2=CC(=C(C=C21)Cl)F)N | Isomeric SMILES | C[C@@H](CN1C=CC2=CC(=C(C=C21)Cl)F)N | Target | Serotonin 2a (5-HT2a) receptor |  | Inhibitor | [1] | Serotonin 2b (5-HT2b) receptor |  | Inhibitor | [2] | Serotonin 2c (5-HT2c) receptor |  | Inhibitor | [1] | Ref 1 | Bioorg Med Chem. 2008 Feb 15;16(4):1966-82. Epub 2007 Nov 4.Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo[2,3-g]indazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists. To Reference | Ref 2 | Bioorg Med Chem Lett. 2006 Feb;16(3):677-80. Epub 2005 Oct 27.Pyrrolo(iso)quinoline derivatives as 5-HT(2C) receptor agonists. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|